In orthopedics, as in life, separation isn’t always loss—sometimes it’s the start of renewed purpose.
Device regulatory pathways, compliance strategies, and reimbursement models shape intrinsic value in medtech, influencing investors, valuations, and long-term growth.
The combined leadership teams from Vascular Technology and Park Medical Electronics will drive the platform’s next phase of growth.
Today’s CDMOs are no longer support players; they are dealmakers, consolidators, and strategic partners.
Innovation isn’t just about growth, it can also shape your exit strategy and attract the attention of strategic buyers.
Maximize success with thorough due diligence in mergers and acquisitions for medtech businesses.
Optimizing supply chain management is no longer a competitive advantage, but rather a necessity.
For all the MedTech manufacturers reading this, what does it actually mean to have operational excellence and true efficiency for your manufacturing? And why does it matter for your stakeholders today and for tomorrow’s exit strategy?